Expert Discussion: PEGASUS-TIMI 54 - Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label data Live from ESC 2017

Dr Dominick Angiolillo graduated from the Catholic University of the Sacred Heart Medical School in Rome, Italy and pursued training in interventional cardiology at the Complutense University of Madrid in Spain and received his Ph.D. in cellular and molecular cardiology. 

In 2004, Dr Angiolillo joined the University of Florida College of Medicine – Jacksonville, where he is a professor of medicine, director of cardiovascular research and director of the interventional cardiology fellowship program. 

Dr Angiolillo has made major scientific contributions to many medical and cardiovascular journals, as well as cardiovascular medicine textbooks. He has authored more than 400 peer-reviewed articles, with nearly 30,000 citations and an H-index of 86. He has authored more than 30 book chapters and is the editor of his own textbook on antithrombotic medicine.

Christoph Varenhorst is associate professor of Cardiology and Senior Consultant Cardiologist at Uppsala University Hospital and Uppsala Clinical Research Center in Uppsala, Sweden. Christoph Varenhorsts research focuses on different aspects of coronary artery disease in both observational real world data sets and experimental clinical trial research.